Inhibikase Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies - Additional Information (Details)

Commitments and Contingencies - Additional Information (Details)						1 Months Ended	12 Months Ended
	Mar. 31, 2022 USD ($) shares	Aug. 01, 2018 USD ($)	Apr. 01, 2014 USD ($) $ / shares shares	Jun. 18, 2010 USD ($) shares	Jun. 08, 2010 USD ($) Agreements shares	Apr. 30, 2018 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($) $ / shares shares	Dec. 31, 2019 shares	Jun. 30, 2018
Loss Contingencies [Line Items]
Operating lease, term of contract										1 year
Lease obligation		$ 54,000
Operating leases description							The total lease obligation was $54,000, payable in 12 equal monthly installments commencing August 1, 2018. Since the end of the one-year initial term on July 31, 2019, the lease continues on a month-to-month basis.
Lease obligation payable monthly installments		12 equal monthly installments
Total potential milestone payments							$ 5,625,000
2020 CEO Agreement
Loss Contingencies [Line Items]
Annual base salary								$ 455,000
Percentage of annual base salary								35.00%
Stock option granted \| shares								100,000
Stock option granted, vesting period								3 years
Stock option granted, exercise price \| $ / shares								$ 10.00
Increase in target bonus, percentage								35.00%
2014 CEO Agreement
Loss Contingencies [Line Items]
Annual base salary			$ 224,000					$ 292,800
Stock option granted \| shares			43,708					21,854	196,685
Stock option granted, vesting period			10 years					12 months
Stock option granted, exercise price \| $ / shares			$ 0.38
2018 Flagship Agreement
Loss Contingencies [Line Items]
Consulting services fee per month						$ 12,500
Consulting services fee accrued						$ 12,500
Agreement ended date description						The 2018 Flagship Agreement ended on December 31, 2020 and the Frattaroli Employment Agreement superseded the 2018 Flagship Agreement in all respects on January 1, 2021.
Emory University License Agreements
Loss Contingencies [Line Items]
License agreements, fair value of shares issued					$ 313,500
Number of license agreements \| Agreements					2
License agreement description					the License A term is the later of 10 years or until the expiration of the patent rights. License B was terminated in May 2013 under the normal course of business.
Total potential milestone payments					$ 280,000		0	$ 0
Emory University License Agreements \| License A [Member]
Loss Contingencies [Line Items]
License agreements, shares issued \| shares					393,370
License agreement, term					10 years
Emory University License Agreements \| License B [Member]
Loss Contingencies [Line Items]
License agreements, fair value of shares issued					$ 437,078
Duke University License Agreement
Loss Contingencies [Line Items]
License agreements, shares issued \| shares				611,909
License agreements, fair value of shares issued				$ 247,500
License agreement, term				10 years
Total potential milestone payments				$ 280,000			0	0
License termination date				April 16, 2020
License termination cost				$ 0
Sphaera Agreement
Loss Contingencies [Line Items]
License agreement, fixed fee paid							$ 160,000
Frattaroli Employment Agreement
Loss Contingencies [Line Items]
Annual base salary								$ 375,000
Percentage of annual base salary								30.00%
Stock option granted \| shares								100,000
Stock option granted, vesting period								3 years
Stock option granted, exercise price \| $ / shares								$ 10.00
Increase in target bonus, percentage								30.00%
Subsequent Event [Member] \| 2020 CEO Agreement
Loss Contingencies [Line Items]
Annual base salary	$ 510,000
Percentage of annual base salary	50.00%
Stock option granted \| shares	125,000
Stock option granted, vesting period	3 years
Increase in target bonus, percentage	50.00%
Subsequent Event [Member] \| 2020 CFO Agreement
Loss Contingencies [Line Items]
Annual base salary	$ 400,000
Percentage of annual base salary	40.00%
Stock option granted \| shares	62,500
Stock option granted, vesting period	3 years
Increase in target bonus, percentage	40.00%
Subsequent Event [Member] \| Frattaroli Employment Agreement
Loss Contingencies [Line Items]
Annual base salary	$ 400,000
Percentage of annual base salary	40.00%
Increase in target bonus, percentage	40.00%